Table 2.
Groups | SOD (U/mg) | MDA (nmol/mg) | Ca2+ (μmol/mg) |
---|---|---|---|
Control | 2980.011 ± 140.288 | 1.165 ± 0.106 | 0.181 ± 0.01 |
PA (125 μM) | 2405.464 ± 90.575## | 1.521 ± 0.032## | 0.224 ± 0.004### |
PA + PCB2 (2.5 μM) | 2953.916 ± 105.401∗∗ | 1.347 ± 0.024 | 0.20 ± 0.007∗∗ |
PA + PCB2 (5 μM) | 3045.872 ± 114.002∗∗ | 1.321 ± 0.022 | 0.196 ± 0.009∗∗∗ |
PA + PCB2 (10 μM) | 3323.062 ± 158.858∗∗∗ | 1.193 ± 0.038∗∗ | 0.19 ± 0.008∗∗∗ |
HepG2 cells were exposed to PA (125 μM) and treated by PCB2 (2.5, 5, and 10 μM) for 24 h. SOD, MDA, and Ca2+ levels were detected by kits, respectively. The bold values are presented as means ± S.D.##P < 0.01 and###P < 0.001 vs control, ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001 vs model groups For SOD level, control vs. PA: P = 0.0066; PA vs. 2.5μM: P = 0.0089; PA vs. 5μM: P = 0.0031; PA vs. 10μM: P = 0.0002. For MDA level, control vs. PA: P = 0.0027; PA vs. 10μM: P = 0.0053. For Ca2+ level, control vs. PA: P<0.0001; PA vs. 2.5μM: P = 0.0014; PA vs. 5μM: P = 0.0003; PA vs. 10μM: P<0.0001. .